JHDAAI Recent Publications

Published in 2025

• “Trust in Government and COVID-19 Preventative Behaviors”
  Yenny Guzman-Ruiz, Joshua Choe, Gerard Anderson, Antonio Trujillo
  Journal of Economic Analysis, January 2025
   

Published in 2024

• “Pharmacy Closures and Anticonvulsant Medication Prescription Fills”
  Kelly Anderson, Maitreyi Sahu, Michael DiStefano, Carl Asche, Joseph Mattingly
  JAMA, November 2024
   
• “Trust in Government and COVID-19 Preventative Behaviors”
  Yenny Guzman-Ruiz, Joshua Choe, Gerard Anderson, Antonio Trujillo
  Journal of Economic Analysis, November 2024
   
• “Does Multiple Biosimilar Entry Slow Down Reference Product Pricing? An Empirical Investigation”
  Morgane Mouslim, Mariana Socal, Antonio Trujillo
  Expert Opinion on Biological Therapy, November 2024
   
• “Strategic Manufacturer Response to the Medicaid Rebate Cap Removal”
  Joseph Levy, Mariana Socal, Jeromie Ballreich
  JAMA Health Forum, November 2024
   
• “Clinical Evidence Supporting FDA Approval of Gene and RNA Therapies for Rare Inherited Conditions”
  Ilina Odouard, Jeromie Ballreich, Branden Lee, Mariana Socal
  Pediatric Drugs, November 2024
   
• “Dynamics of Biological Markets With Multiple Biosimilar Competitors in the United States”
  Morgane Mouslim, Mariana Socal, Antonio Trujillo
  Expert Opinion Biological Therapies, October 2024
   
• “Biopharmaceutical Pipeline Funded by Venture Capital Firms, 2014 to 2024”
  So-Yeon Kang, Mingqian Liu, Jeromie Ballreich, Ravi Gupta, Gerard Anderson
  Health Affairs Scholar, October 2024
   
• “Medigap-Guaranteed Issue Associated with Medicare Advantage Disenrollment for Beneficiaries Administered a Part B Drug”
  Angela Liu, David Pittman, Gerard Anderson, Jianhui Xu
  Health Affairs Scholar, October 2024
   
• “On the Motivation for Pharmaceutical Manufacturer Coupons: Brand Loyalty or Customer Acquisition?”
  Jason Gibbons, Manuel Hermosilla, Antonio Trujillo
  Health Services Research, September 2024
   
• “Manufacturer-Sponsored Drug Coupon Use and Drug-Switching Behavior Among Patients with Type 2 Diabetes”
  Yang Wang, So-Yeon Kang, Mariana Socal, Stacie Dusetzina
  Journal of Managed Care Specialty Pharmacy, September 2024
   
• “Macular Degeneration Drug Prescribing Patterns After Step Therapy Introduction in Medicare Advantage”
  Angela Liu, Kelly Anderson, Joseph Levy, Thomas Johnson, Daniel Polsky, Gerard Anderson
  JAMA Network Health Forum, August 2024
   
• “Consumer Perceptions of Safety Information in Direct-to-Consumer Print Advertisements for Alzheimer Drugs”
  Jenny Markell, Ilina Odouard, Gerard Anderson, Michael DiStefano
  JAMA Network Open, August 2024
   
• “Medicaid Spending and Utilization of Gene and RNA Therapies for Rare Inherited Conditions”
  Ilina Odouard, Jeromie Ballreich, Mariana Socal
  Health Affairs Scholar, May 2024
   
• “Emergency Department Trauma Activation Fees by Payer Type”
  Yuchen Wang, Victoria Liu, Yang Wang, Ge Bai, Renee Hsia
  JAMA Surgery, April 2024
   
• “Global Production of Active Pharmaceutical Ingredients for US Generic Drugs Experiencing Shortages”
  Mariana Socal, Matthew Crane, Gerard Anderson
  JAMA Network, April 2024
   
• “Drug Shortages – A Study in Complexity”
  Mariana Socal, Joshua Sharfstein
  JAMA Network Open, April 2024
   
• “Adjusting Starting Points for Initial Price Offers:      The Example of Ibrutinib”
  Jason Gibbons, Charles Bennett, Kenneth Carson, Gerard Anderson
  American Journal of Managed Care, April 2024
   
• “Regulating Ethical Experimentation: Impacts of the Breakthrough Therapy Designation on Drug R&D”
  Manuel Hermosilla
  Journal of Health Economics, March 2024
   
• “Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in Medicaid”
  Antal Zemplenyi, Jim Leonard, Michael DiStefano, Kelly Anderson, Garth Wright, Nicholas Mendola, Kavita Nair, Brett McQueen
  Pharmacoeconomics, March 2024
   
• “Association of Hospitals’ Experience with Bundled Payment for Care Improvement Model with the Diffusion of Acute Hospital Care at Home”
  So-Yeon Kang
  Health Services Research, March 2024
   
• “Sociodemographic and Spending Characteristics of Medicare Beneficiaries Taking Prescription Drugs Subject to Price Negotiations”
  Ilina Odouard, Gerard Anderson, Caleb Alexander, Jeromie Ballreich
  Journal of Managed Care Specialty Pharmacy, March 2024
   
• “Hospital and Physician Group Practice Participation in Prior and Next-Generation Value-Based Payment Programs”
  So-Yeon Kang, Gerard Anderson
  JAMA Network Open, February 2024
   
• “Ownership and Interoperability Challenges of Alzheimer Monoclonal Antibody Registries”
  Mariana Socal, Ilina Odouard, Hadi Kharrazi
  JAMA Neurology, February 2024
   
• “Congressional Investigation of RevAssist-Linked and General Pricing Strategies for Lenalidomide”
  Charles Bennett, Jason Gibbons, Antonio Trujillo, Kenneth Carson, Kevin Knopf, Chadi Nabhan, Steven Rosen, David Aboulafia
  JCO Oncology Practice, February 2024
   
• “Do Insurers With Greater Market Power Negotiate Consistently Lower Prices for Hospital Care?  Evidence From Hospital Price Transparency Data”
  Yang Wang, Mark Meiselbach, Jianhui Xu, Ge Bai, Gerard Anderson
  Medical Care Research and Review, February 2024
   
• “Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates”
  Jeremy Costin, Morgane Mouslim, Mariana Socal, Antonio Trujillo
  PharmacoEconomics Open, January 2024
   
• “Pediatric Drugs, Accelerated Approval, and Prospects for Reform”
  Jeromie Ballreich, Hyung-Seok Kim, Mariana Socal
  Pediatric Drugs, January 2024
   
• “Addressing the Drug-Shortage Crisis in Oncology”
  Y. Tony Yang, Mariana Socal, Charles Bennett
  JAMA Oncology, January 2024
   
• “Congressional Investigation of RevAssist-Linked and General Pricing Strategies for Lenalidomide”
  Charles Bennett, Jason Gibbons, Antonio Trujillo, Kenneth Carson, Kevin Knopf, Chadi Nabhan, Steven Rosen, David Aboulafia
  JCO Oncology Practice, January 2024
   
• “Characteristics of Prescription Drug Fills Using Pharmacy-Pharmacy Benefit Manager Discount Programs:  The “GoodRx” Model”
  Jill Curran, Yuchen Wang, So-Yeon Kang, Andrew Xuan, Gerard Anderson, Ge Bai, Caleb Alexander
  Value in Health, January 2024
   
• “Filgrastim and Infliximab Biosimilar Uptake in Medicare Advantage Compared with Traditional Medicare, 2016-2019”
  Angela Liu, Andrew Xuan, Mariana Socal, Gerard Anderson, Kelly Anderson
  Journal of Managed Care Specialty Pharmacy, January 2024
   
• “Enrollment Trends in Self-Funded Employer-Sponsored Insurance, 2015 and 2021”
  Mark Meiselbach, Jeffrey Marr, Yang Wang
  Health Affairs, January 2024
   
• “Spending on Dual Over-the-Counter and Prescription Drugs in the Medicare Part D Program”
  Mariana Socal, Yuchen Wang, Elizabeth Plummer, Gerard Anderson, Ge Bai
  JAMA, January 2024
   
• “Assessing Clinical Benefit in the Medicare Drug Price Negotiation Program: A 2-Step Approach for Improving Transparency, Consistency, and Meaningful Patient Engagement”
  Michael DiStefano, Antal Zemplenyi, Brett McQueen
  Journal of Managed Care and Specialty Pharmacy, January 2024